Shares of AbbVie (NYSE:ABBV) are surging 7% this morning after the pharmaceutical giant reported solid fourth quarter earnings as two key immunology drugs continue to enjoy significant support.
Key Points It’s a good idea to factor extra expenses into your savings plans. Make a list of possibilities based on your ...